(Q37026045)

17 August 2017

1 reference

title

Intracardiac and intrarenal renin-angiotensin systems: mechanisms of cardiovascular and renal effects (English)

1 reference

17 August 2017

1 reference

Veena Raizada

1

1 reference

17 August 2017

Betty Skipper

series ordinal

2

1 reference

17 August 2017

Wentao Luo

series ordinal

3

1 reference

17 August 2017

Jeffrey Griffith

series ordinal

4

1 reference

17 August 2017

publication date

1 November 2007

1 reference

Journal of Investigative Medicine

17 August 2017

published in

1 reference

17 August 2017

volume

55

1 reference

17 August 2017

issue

7

1 reference

17 August 2017

page(s)

341-359

1 reference

Renin uptake by the endothelium mediates vascular angiotensin formation

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2310%2F6650.2007.00020

Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2007.00020

Experimental cardiac fibrosis: differential time course of responses to mineralocorticoid-salt administration

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2007.00020

Aldosterone, mineralocorticoid receptors and vascular inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2007.00020

The cardiac renin-angiotensin system: conceptual, or a regulator of cardiac function?

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2007.00020

Cardiac intracrine renin angiotensin system. Part of genetic reprogramming?

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2007.00020

Is angiotensin II made inside or outside of the cell?

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2007.00020

Ang II accumulation in rat renal endosomes during Ang II-induced hypertension: role of AT(1) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2007.00020

Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2007.00020

Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2007.00020

Myocardial osteopontin expression coincides with the development of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2007.00020

Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2007.00020

Modulation of sympathetic coronary vasoconstriction by cardiac renin-angiotensin system in human coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2007.00020

Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2007.00020

Endothelium-derived steroidogenic factor enhances angiotensin II-stimulated aldosterone release by bovine zona glomerulosa cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2007.00020

Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2007.00020

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2007.00020

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2007.00020

Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2007.00020

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2007.00020

Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2007.00020

Gemfibrozil decreases atherosclerosis in experimental diabetes in association with a reduction in oxidative stress and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2007.00020

Aldosterone impairs bone marrow-derived progenitor cell formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F6650.2007.00020

21 January 2018

Identifiers

DOI

10.2310/6650.2007.00020

1 reference

17 August 2017

1 reference